TrakCel, a Cardiff, Wales, UK-based cellular orchestration platform developer, received a multi-million dollar investment from San Francisco-based Telegraph Hill Partners.
The company intends to use the funds for growth activities. Concurrent with the financing, Matt Mackowski, Tom Raffin M.D., and Rob Hart, CFA from Telegraph Hill Partners, will join the company’s Board.
The company will use the funds to further enhance its technology platform and catalyze its global growth plans.
Led by Ravi Nalliah, CEO, TrakCel provides a cell, gene and immunotherapy management solution to improve clinical study efficacy. The technology provides interactive instructions to professionals across the supply chain and gives stakeholders on-demand visibility of procedural results and chain-of-custody data for immediate traceability, validation and compliance audits.
The company recently signed significant new contracts in the USA and opened its US office in Newport Beach California.